Search

Study to Evaluate DNL151 in Subjects With Parkinson's Disease

Trial Phase 1 Completed April 17, 2023

Parkinson's Disease Inpatient Clinical Knowledge and Management

Trial N/A Terminated April 17, 2023

Predictive Indices of Independent Activity of Daily-living in Neurorehabilitation

Trial N/A Unknown April 17, 2023

Evaluation of Bilateral Gamma Knife Thalamotomy in Patients Presenting With Severe Essential Tremor

Trial N/A Completed April 13, 2023

Evaluation of the Safety and Efficacy of Bilateral Subthalamic Nucleus (SNT) Radiosurgery in Idiopathic Severe Parkinson's Disease Fulfilling Inclusion Criteria for STN Deep Brain Stimulation and Presenting With a Contraindication to Intracerebral Electrode Implantation.

Trial N/A Completed April 13, 2023

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects

Trial Phase 1 Completed April 12, 2023

iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDS

Trial N/A Not yet recruiting April 11, 2023

Azilect® In Wearing-Off (AIWO)

Trial N/A Completed April 11, 2023

Constipation and Changes in the Gut Flora in Parkinson's Disease

Trial N/A Unknown April 11, 2023

Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease

Trial Phase 3 Completed April 11, 2023

Stereotactic Transplantation of hAESCs for Parkinson's Disease

Trial Early Phase 1 Completed April 11, 2023

Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's Disease

Trial Phase 2 Terminated April 11, 2023

The Effects of Tele-rehabilitation Interventions in Parkinson's Patients

Trial N/A Completed April 11, 2023

A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

Trial Phase 1 Unknown April 10, 2023

Aqua Stand-Up Paddle Balance Effect in Parkinson's Disease (AquaSUP PARK)

Trial N/A Completed April 9, 2023

Progression in Cognitive ADLs in Parkinson's Disease

Trial N/A Unknown April 9, 2023

Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease

Trial Phase 2 Completed April 6, 2023

Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties

Trial N/A Completed April 6, 2023

Programmes de Marche Active et qualité de Vie Dans la Maladie de Parkinson

Trial N/A Withdrawn April 5, 2023

Gait Training With antiGRAVIty TREadmill 'Alter-G', in Patients With ParkinSON Disease

Trial N/A Unknown April 5, 2023